MERTK and cancer: Indeed, consistent with this interpretation, TAM receptors, including Mertk, while not commonly mutated in cancers [34], can often become up-regulated by enhanced transcriptional activation [35] or by post-translational effector mechanisms such as receptor ectodomain shedding and ubiquitin-mediated degradation [12,36].